1. Home
  2. KLTOW vs REGCP Comparison

KLTOW vs REGCP Comparison

Compare KLTOW & REGCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • REGCP
  • Stock Information
  • Founded
  • KLTOW N/A
  • REGCP N/A
  • Country
  • KLTOW United States
  • REGCP United States
  • Employees
  • KLTOW 3
  • REGCP 500
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • REGCP
  • Sector
  • KLTOW Health Care
  • REGCP
  • Exchange
  • KLTOW Nasdaq
  • REGCP Nasdaq
  • Market Cap
  • KLTOW N/A
  • REGCP N/A
  • IPO Year
  • KLTOW 2022
  • REGCP N/A
  • Fundamental
  • Price
  • KLTOW $0.13
  • REGCP $23.75
  • Analyst Decision
  • KLTOW
  • REGCP
  • Analyst Count
  • KLTOW 0
  • REGCP 0
  • Target Price
  • KLTOW N/A
  • REGCP N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • REGCP N/A
  • Earning Date
  • KLTOW N/A
  • REGCP N/A
  • Dividend Yield
  • KLTOW N/A
  • REGCP N/A
  • EPS Growth
  • KLTOW N/A
  • REGCP N/A
  • EPS
  • KLTOW N/A
  • REGCP N/A
  • Revenue
  • KLTOW N/A
  • REGCP N/A
  • Revenue This Year
  • KLTOW N/A
  • REGCP N/A
  • Revenue Next Year
  • KLTOW N/A
  • REGCP N/A
  • P/E Ratio
  • KLTOW N/A
  • REGCP N/A
  • Revenue Growth
  • KLTOW N/A
  • REGCP N/A
  • 52 Week Low
  • KLTOW N/A
  • REGCP N/A
  • 52 Week High
  • KLTOW N/A
  • REGCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW 41.58
  • REGCP 45.85
  • Support Level
  • KLTOW $0.13
  • REGCP $23.52
  • Resistance Level
  • KLTOW $0.18
  • REGCP $23.99
  • Average True Range (ATR)
  • KLTOW 0.02
  • REGCP 0.18
  • MACD
  • KLTOW -0.00
  • REGCP 0.02
  • Stochastic Oscillator
  • KLTOW 1.79
  • REGCP 27.71

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About REGCP Regency Centers Corporation

Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.

Share on Social Networks: